Protecting Newborns from Congenital Syphilis - Scorecard - MDSpire

Protecting Newborns from Congenital Syphilis

  • July 10, 2026

  • 6 min

Share

Clinical Scorecard: Protecting Newborns from Congenital Syphilis

At a Glance

CategoryDetail
ConditionCongenital Syphilis
Key MechanismsTransmission from mother to child during pregnancy or delivery, leading to serious health consequences.
Target PopulationPregnant women and newborns.
Care SettingPrenatal care and maternal health services.

Key Highlights

  • Congenital syphilis cases in the US reached nearly 4,000 in 2024.
  • 40% of congenital syphilis cases occur in mothers who did not receive prenatal care.
  • Testing for syphilis should be universal for all pregnant women, ideally at the first prenatal visit.
  • Penicillin G benzathine is an effective treatment for syphilis.
  • Awareness and access to care are critical in reducing congenital syphilis rates.

Guideline-Based Recommendations

Diagnosis

  • Use serological tests including nontreponemal and treponemal tests for accurate diagnosis.

Management

  • Treat syphilis with penicillin G benzathine and ensure timely follow-up.

Monitoring & Follow-up

  • Repeat syphilis testing during the third trimester and at delivery.

Risks

  • Missed prenatal care and delayed treatment increase the risk of congenital syphilis.

Patient & Prescribing Data

Pregnant women at risk for syphilis.

Timely treatment with penicillin is crucial to prevent transmission to the infant.

Clinical Best Practices

  • Implement universal syphilis screening for all pregnant women.
  • Enhance awareness and education about syphilis among healthcare providers.
  • Improve access to prenatal care and syphilis testing in high-prevalence areas.

Related Resources & Content

Original Source(s)

Related Content